Day One Biopharmaceuticals Stock Alpha and Beta Analysis

DAWN Stock  USD 8.23  0.10  1.20%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Day One Biopharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Day One over a specified time horizon. Remember, high Day One's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Day One's market risk premium analysis include:
Beta
0.91
Alpha
(0.52)
Risk
4.26
Sharpe Ratio
(0.14)
Expected Return
(0.62)
Please note that although Day One alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Day One did 0.52  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Day One Biopharmaceuticals stock's relative risk over its benchmark. Day One Biopharmaceu has a beta of 0.91  . Day One returns are very sensitive to returns on the market. As the market goes up or down, Day One is expected to follow. At this time, Day One's Book Value Per Share is very stable compared to the past year. As of the 22nd of March 2025, Tangible Book Value Per Share is likely to grow to 5.46, while Enterprise Value Over EBITDA is likely to drop (5.14).

Enterprise Value

1.27 Billion

19%
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Day One Backtesting, Day One Valuation, Day One Correlation, Day One Hype Analysis, Day One Volatility, Day One History and analyze Day One Performance.

Day One Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Day One market risk premium is the additional return an investor will receive from holding Day One long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Day One. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Day One's performance over market.
α-0.52   β0.91
100%

Day One expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Day One's Buy-and-hold return. Our buy-and-hold chart shows how Day One performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Day One Market Price Analysis

Market price analysis indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By understating and applying Day One stock market price indicators, traders can identify Day One position entry and exit signals to maximize returns.

Day One Return and Market Media

The median price of Day One for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 is 12.2 with a coefficient of variation of 14.92. The daily time series for the period is distributed with a sample standard deviation of 1.69, arithmetic mean of 11.36, and mean deviation of 1.45. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
JavaScript chart by amCharts 3.21.151234567891011122025FebMar -30-20-100
JavaScript chart by amCharts 3.21.15Day One Biopharmaceu Day One Biopharmaceu Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Acquisition by Adam Dubow of 59000 shares of Day One subject to Rule 16b-3
01/15/2025
2
Disposition of 2675 shares by York Charles N Ii of Day One at 16.0787 subject to Rule 16b-3
01/17/2025
3
Why Is Andreas Halvorsen Bullish On Day One Biopharmaceuticals, Inc. Now - Yahoo Finance
01/22/2025
4
Disposition of 12048 shares by Bender Jeremy of Day One at 11.963 subject to Rule 16b-3
02/18/2025
5
Dawn Protocol 24-Hour Trading Volume Reaches 33.98
02/19/2025
6
DAWN calls on International Criminal Court to Investigate Biden administration for Aiding and Abetting Israeli Crimes in Gaza
02/24/2025
7
DAWN
02/25/2025
8
Day One Biopharmaceuticals Announces Earnings Results, Misses Expectations By 0.34 EPS
02/27/2025
9
Day One Biopharmaceuticals, Inc. A Bull Case Theory
03/05/2025
10
Buy Rating for Day One Biopharmaceuticals Strong Financial Position and Strategic Growth Potential - TipRanks
03/11/2025
11
Disposition of 2206 shares by Blackman Samuel C. of Day One at 13.2102 subject to Rule 16b-3
03/14/2025
12
Has Successfully Launched in China
03/18/2025

About Day One Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Day or other stocks. Alpha measures the amount that position in Day One Biopharmaceu has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Payables Turnover1.621.7
Days Of Inventory On Hand206.66183.7

Day One Upcoming Company Events

As portrayed in its financial statements, the presentation of Day One's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Day One's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Day One's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Day One. Please utilize our Beneish M Score to check the likelihood of Day One's management manipulating its earnings.
4th of March 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Day One

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Day One technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Day One trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

News Freq…Investor S…